J&J On Warpath Over Schizophrenia Drug
Johnson & Johnson has slapped Canadian drug maker Apotex Inc. with a patent infringement lawsuit, the latest attempt to thwart generic versions of its blockbuster antipsychotic drug Risperdal from entering the...To view the full article, register now.
Already a subscriber? Click here to view full article